On 2026-05-07, Generate Biomedicines, Inc. (GENB) announced earnings per share of -1.07 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of -0.48.

The next expected annoucement date for quarterly earnings is 2026-08-06, with an average estimated earnings per share of -0.48 for the fiscal quarter ending 2026-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.